Abstract Submission

General Conditions

Abstracts are required for all oral and poster presentations.
Abstracts must be submitted by 8 January 2025 (23:59 CEST)
Abstracts must be submitted in English.
Accepted abstracts will be published in the abstract book by Acta Dermato-Venereologica and in the conference app. By submitting an abstract, you consent to giving NCDV 2025 permission to publish your abstract.
Withdrawal of abstracts is only accepted if notified in writing and subsequently confirmed by the NCDV 2025 Conference Organiser.

Presenting author and registration

The presenting author must register as an active participant at the conference at the latest 14 days after acceptance of an abstract.
NCDV 2025 reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration at the latest 14 days after notification on acceptance.

Contents of your abstract

The abstract word limit is max. 250 words per abstract.
The title should be as brief as possible but long enough to clearly indicate the nature of the study.
Names of authors should not be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.
The abstract must include the following:

Purpose: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present your results in a logical sequence in text.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.

All abbreviations must be defined in first use.
Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
The abstract should not include; illustrations (including figures, tables and photos), references and funding acknowledgements.
Generic names must be used for all references to products or companies. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. NCDV 2025 reserves the right to replace any brand name with a generic name without further notice.

Topics

Abstracts can be submitted within the following topics:

Reviewing

The Scientific Committee will review the abstract.
Notification of acceptance or rejection of the abstract will be sent directly to all presenting authors (and submitters) by email.
It is the responsibility of all investigators that all studies are performed with respect to national legislation, international legislation and ethical guidelines for medical research involving humans and/or animals. The Scientific Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
Please verify that your email address (submitter and presenting author) is correct, as it will be used for contacting you after the review process.

For all inquiries regarding the abstract submission, please contact the Conference Organiser, c/o CAP Partner at: info@cap-partner.eu

Abstract submission status:
Open